Fighting antimicrobial resistance in sexually transmitted infections with targeted diagnostics

Webinar overview

Antimicrobial resistance (AMR) has become one of the most pressing public health crises, with sexually-transmitted infections (STIs) of all types rapidly becoming resistant to treatments.

One such infection of pressing concern is Mycoplasma genitalium, otherwise known as MG, which can cause non-specific urethritis (NSU) in men and pelvic inflammatory disease (PID) in women.

In this SelectScience webinar, three experts discuss how they combined their expertise to deliver a resistance-guided therapy approach for the successful treatment and management of sexually-transmitted infections (STIs), particularly in Mycoplasma genitalium, achieving 96% cure rates.